moxifloxacin has been researched along with Erysipelas in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Arvis, P; Bogner, JR; Esguerra-Alcalen, M; Heldner, S; Kutaiman, A | 1 |
Jacobs, F; Kubiak, J; Schaller, M; Stroelin, A | 1 |
2 other study(ies) available for moxifloxacin and Erysipelas
Article | Year |
---|---|
Moxifloxacin in complicated skin and skin structure infections (cSSSIs): A prospective, international, non-interventional, observational study.
Topics: Abscess; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Aza Compounds; Bites and Stings; Cellulitis; Cohort Studies; Debridement; Diabetic Foot; Drainage; Erysipelas; Female; Fluoroquinolones; Humans; Male; Middle Aged; Moxifloxacin; Prospective Studies; Quinolines; Skin Diseases, Bacterial; Skin Ulcer; Surgical Wound Infection; Treatment Outcome; Young Adult | 2013 |
Recurrent erysipelas secondary to a late prosthetic femoropopliteal bypass infection.
Topics: Aged; Anti-Infective Agents; Aza Compounds; Blood Vessel Prosthesis; Clindamycin; Coated Materials, Biocompatible; Erysipelas; Femoral Artery; Fluoroquinolones; Humans; Male; Moxifloxacin; Penicillin G; Peripheral Vascular Diseases; Popliteal Artery; Prosthesis-Related Infections; Quinolines; Recurrence; Reoperation | 2013 |